Online Program Home
  My Program

Keyword Search

Legend:
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: two-stage returned 11 record(s)
Monday, 07/31/2017
Two-Stage Design for Phase II Cancer Clinical Trials with Multiple Endpoints
Hui Gu, Rutgers University; Yong Lin, Rutgers; Weichung Joe Shih, Rutgers School of Public Health; Yaqun Wang, Rutgers; Kejian Liu, Celgene


Photometric Classification of Supernova with Biased Training Set
David Van Dyk, Imperial College London; Roberto Trotta, Imperial College London; Esben Revsbech, Imperial College London
10:35 AM

Estimators and Confidence Intervals for Adaptive Two-Stage Designs for Population Enrichment
Vladimir Dragalin, Janssen R&D; Ionut Bebu, The George Washington University
10:55 AM

Sensitivity Analysis and Power in the Presence of Many Weak Instruments with Application to the Effect of Incarceration on Future Earnings
Ashkan Ertefaie, University of Rochester; Dylan Small, University of Pennsylvania
2:50 PM

Tuesday, 08/01/2017
A Two-Stage Design for Phase III Trials with Population Selection
Wen Li, Merck & Co. Inc.
8:50 AM

A Two-Stage Algorithm for Computation of the Exact Distribution of Sums of Spacings
Chien-Tai Lin, Tamkang University; Chung-Tao Lu, E.Sun Bank
10:50 AM

Extension of the Two-Stage Randomized Trial Design for Testing Treatment, Self-Selection, and Treatment Preference Effects to Binary Outcomes
Briana Cameron, Yale University; Denise Esserman, Yale School of Public Health; Peter Peduzzi, Yale School of Public Health
12:05 PM

Identifiability and Inference of Causal Effects with High-Dimensional and Invalid Instruments
Changjing Wu, Peking University; Minghua Deng, Peking University; Wei Lin, Peking University
3:20 PM

A Selective Inference-Based Two-Stage Procedure for Clinical Safety Studies
Yalin Zhu, New Jersey Institute of Technology; Wenge Guo, New Jersey Institute of Technology
3:20 PM

Wednesday, 08/02/2017
Testing for Genetic Association in Case-Control Studies Incorporating Multivariate Disease Characteristics
Haoyu Zhang, Johns Hopkins Bloomberg SPH; Thomas U. Ahearn, National Cancer Institute Division of Cancer Epidemiology & Genetics; Montserrat GarcĂ­a-Closas, National Cancer Institute Division of Cancer Epidemiology & Genetics; Nilanjan Chatterjee, Johns Hopkins University
2:25 PM

Thursday, 08/03/2017
A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy
Michelle DeVeaux, Yale University; Daniel Zelterman, Yale University; Michael Kane, Yale University
11:20 AM

 
 
Copyright © American Statistical Association